NDC 50090-4414
Spiriva 18 ug capsule
On the label: A-S Medication Solutions. It's repackaged: A-S Medication Solutions rebottles it from Boehringer Ingelheim Pharmaceuticals, Inc.'s NDC 0597-0075.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Boehringer Ingelheim Pharmaceuticals, Inc. names for other drugs.
Repackaging site
- A-S Medication Solutions LLC, Libertyville, IL, United States · relabels it
Recalls
- Jan 26, 2022 · Class II · Cardinal Healthcare
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots: Batch 104440 - Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: 5098 - Dec 14, 2017 · Class II · Boehringer Ingelheim Pharmaceuticals, Inc.
Failed Stability Specifications
Lots: Lot # 606478; Exp. 03/18 - Mar 27, 2014 · Class III · Boehringer Ingelheim Roxane Inc
Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.
Lots: a) 5 count capsule blister card: 303012A, Exp Sep 2014; b) 30 count capsules blister card: 303012B, Exp Sep 2014, 303125A, 303253A, Exp Oct 2014, 303895A, 304282A, Exp Nov 2014, 304510A, Exp Dec 2014 - Aug 30, 2013 · Class III · Boehringer Ingelheim Roxane Inc
Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler
Lots: Lot Number/Exp. Date: 202477A/Sep-13, 202480A/Sep-13, 202556B/Sep-13, 202603A/Sep-13, 202784B/Sep-13, 202844A/Sep-13, 202951A/Sep-13, 203041A/Sep-13, 203042A,Sep-13, 203280A/Oct-13, 203281A/Oct-13, 203364A/Oct-13, 203440A,Oct-13, 203569B/Oct-13, 203588A/Oct-13, 203890B/Nov-13, 204094A/Nov-13, …
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Tiotropium: every company that makes it
- Form
- capsule
- Strength
- 18 ug
- Approval
- NDA NDA021395
- On the market since
- Oct 11, 2005
- Package NDCs
50090-4414-0- Official label
- DailyMed (National Library of Medicine), updated May 15, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?